Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Reproductive Biomedicine Online|October 8, 2025
Minimizing waste in medically assisted reproduction: a study on sustainability initiatives for oocyte retrieval and embryo transferRoos A Sluimer, Theodora C van Tilborg, Ralph J A Oude Ophuis, et al.Reproductive Biomedicine Online|April 25, 2026
The DIVINE dose-selection model in daily ART practice: effects on live birth rate and safetyNienke E Schouten, Theodora C van Tilborg, Daniela Cianci, et al.Acta Obstetricia Et Gynecologica Scandinavica|October 1, 2016
Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic reviewTheodora C van Tilborg, Frank J M Broekmans, Madeleine Dólleman, et al.Human Reproduction (Oxford, England)|September 1, 2017
Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?Simone C Oudshoorn, Theodora C van Tilborg, Ouijdane Hamdine, et al.Human Reproduction (Oxford, England)|December 16, 2019
Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low respondersJori A Leijdekkers, Helen L Torrance, Nienke E Schouten, et al.Clinical Journal of the American Society of Nephrology : CJASN|August 29, 2020
Preimplantation Genetic Testing for Monogenic Kidney DiseaseRozemarijn Snoek, Marijn F Stokman, Klaske D Lichtenbelt, et al.Human Reproduction (Oxford, England)|November 10, 2017
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responderTheodora C van Tilborg, Helen L Torrance, Simone C Oudshoorn, et al.Human Reproduction (Oxford, England)|May 25, 2019
Cumulative live birth rates in low-prognosis womenJori A Leijdekkers, Marinus J C Eijkemans, Theodora C van Tilborg, et al.Menopause (New York, N.Y.)|June 22, 2016
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?Theodora C van Tilborg, Frank J Broekmans, Anouk Pijpe, et al.Acta Obstetricia Et Gynecologica Scandinavica|May 26, 2019
Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trialJori A Leijdekkers, Theodora C van Tilborg, Helen L Torrance, et al.Pageof 2